LORI HESTAND: Open Payments
NPI 1326377177 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 35 payments from 13 companies in 2025. Trend: 2023 $1,855 · 2024 $1,481 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $314 |
| Supernus Pharmaceuticals, Inc. | 6 | $121 |
| Lundbeck LLC | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Tris Pharma Inc | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $50 |
| Alkermes, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Noven Therapeutics, LLC | 1 | $21 |
Products named: CAPLYTA, Qelbree, REXULTI, Auvelity, Dyanavel XR, INGREZZA, ARISTADA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
